State Street’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $851K | Buy |
|
|||||
|
2022
Q2 | $1.09M | Sell |
|
|||||
|
2022
Q1 | $5.29M | Sell |
|
|||||
|
2021
Q4 | $43.7M | Buy |
|
|||||
|
2021
Q3 | $65.4M | Buy |
|
|||||
|
2021
Q2 | $57.5M | Buy |
|
|||||
|
2021
Q1 | $69.4M | Sell |
|
|||||
|
2020
Q4 | $69.8M | Buy |
|
|||||
|
2020
Q3 | $56.2M | Buy |
|
|||||
|
2020
Q2 | $62.4M | Buy |
|
|||||
|
2020
Q1 | $23.3M | Buy |
|
|||||
|
2019
Q4 | $38.2M | Buy |
|
|||||
|
2019
Q3 | $3.9M | Sell |
|
|||||
|
2019
Q2 | $79.3M | Buy |
|
|||||
|
2019
Q1 | $84.4M | Buy |
|
|||||
|
2018
Q4 | $61M | Buy |
|
|||||
|
2018
Q3 | $89.8M | Buy |
|
|||||
|
2018
Q2 | $112M | Buy |
|
|||||
|
2018
Q1 | $109M | Buy |
|
|||||
|
2017
Q4 | $128M | Sell |
|
|||||
|
2017
Q3 | $164M | Buy |
|
|||||
|
2017
Q2 | $182M | Buy |
|
|||||
|
2017
Q1 | $119M | Sell |
|
|||||
|
2016
Q4 | $95.1M | Buy |
|
|||||
|
2016
Q3 | $39.9M | Sell |
|
|||||
|
2016
Q2 | $22.4M | Sell |
|
|||||
|
2016
Q1 | $34.5M | Buy |
|
|||||
|
2015
Q4 | $51.9M | Buy |
|
|||||
|
2015
Q3 | $67.3M | Buy |
|
|||||
|
2015
Q2 | $62M | Buy |
|
|||||
|
2015
Q1 | $50.4M | Sell |
|
|||||
|
2014
Q4 | $38.8M | Sell |
|
|||||
|
2014
Q3 | $32.1M | Buy |
|
|||||
|
2014
Q2 | $27.9M | Buy |
|
|||||
|
2014
Q1 | $36.9M | Sell |
|
|||||
|
2013
Q4 | $34.2M | Buy |
|
|||||
|
2013
Q3 | $34.1M | Buy |
|
|||||
|
2013
Q2 | $24.5M | Buy |
|